Yifeng Pharmacy Chain Co., Ltd.

SHSE:603939 Stock Report

Market Cap: CN¥29.6b

Yifeng Pharmacy Chain Dividends and Buybacks

Dividend criteria checks 3/6

Yifeng Pharmacy Chain is a dividend paying company with a current yield of 2.04% that is well covered by earnings.

Key information

2.0%

Dividend yield

0.01%

Buyback Yield

Total Shareholder Yield2.0%
Future Dividend Yield3.8%
Dividend Growth14.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.500
Payout ratio53%

Recent dividend and buyback updates

No updates

Recent updates

Returns On Capital At Yifeng Pharmacy Chain (SHSE:603939) Have Stalled

Dec 12
Returns On Capital At Yifeng Pharmacy Chain (SHSE:603939) Have Stalled

We Like The Quality Of Yifeng Pharmacy Chain's (SHSE:603939) Earnings

Nov 06
We Like The Quality Of Yifeng Pharmacy Chain's (SHSE:603939) Earnings

The Market Lifts Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Shares 28% But It Can Do More

Sep 27
The Market Lifts Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Shares 28% But It Can Do More

Investors Met With Slowing Returns on Capital At Yifeng Pharmacy Chain (SHSE:603939)

Jul 29
Investors Met With Slowing Returns on Capital At Yifeng Pharmacy Chain (SHSE:603939)

Slammed 27% Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Screens Well Here But There Might Be A Catch

Jun 20
Slammed 27% Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Screens Well Here But There Might Be A Catch

Yifeng Pharmacy Chain (SHSE:603939) Seems To Use Debt Rather Sparingly

May 24
Yifeng Pharmacy Chain (SHSE:603939) Seems To Use Debt Rather Sparingly

Yifeng Pharmacy Chain's (SHSE:603939) Solid Earnings Are Supported By Other Strong Factors

May 06
Yifeng Pharmacy Chain's (SHSE:603939) Solid Earnings Are Supported By Other Strong Factors

Is Now The Time To Put Yifeng Pharmacy Chain (SHSE:603939) On Your Watchlist?

Apr 13
Is Now The Time To Put Yifeng Pharmacy Chain (SHSE:603939) On Your Watchlist?

Market Participants Recognise Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Earnings

Mar 28
Market Participants Recognise Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Earnings

Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Intrinsic Value Is Potentially 100% Above Its Share Price

Mar 13
Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Intrinsic Value Is Potentially 100% Above Its Share Price

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 603939 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 603939's dividend payments have increased, but the company has only paid a dividend for 9 years.


Dividend Yield vs Market

Yifeng Pharmacy Chain Dividend Yield vs Market
How does 603939 dividend yield compare to the market?
SegmentDividend Yield
Company (603939)2.0%
Market Bottom 25% (CN)0.6%
Market Top 25% (CN)2.3%
Industry Average (Consumer Retailing)2.0%
Analyst forecast (603939) (up to 3 years)3.8%

Notable Dividend: 603939's dividend (2.04%) is higher than the bottom 25% of dividend payers in the CN market (0.59%).

High Dividend: 603939's dividend (2.04%) is low compared to the top 25% of dividend payers in the CN market (2.26%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (53.1%), 603939's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (14.1%), 603939's dividend payments are thoroughly covered by cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 17:06
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yifeng Pharmacy Chain Co., Ltd. is covered by 23 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ethan CuiBofA Global Research
Hao WuChasing Securities
Qianyi LiChina International Capital Corporation Limited